Clinical Trial Update: Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the combination of Metformin and Secukinumab for moderate-to-severe plaque psoriasis in overweight or obese Chinese patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• Cosentyx (secukinumab)
• metformin (metformin)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Psoriasis, Plaque Psoriasis | Phase 4 | Status: NOT_YET_RECRUITING